Login to Your Account



EPIX In $28M Deal To Develop Contrast Agents With Schering

By Aaron Lorenzo


Wednesday, May 28, 2003
EPIX Medical Inc. is returning to a familiar partner, Schering AG, to develop contrast agents for use in MRI in a deal that could garner up to $28 million in near-term money for EPIX.(BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription